首页> Leukemia> Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.

导出 OA

翻译打印收藏纠错

第一作者： Andreas,Hochhaus

第一单位： Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany. andreas.hochhaus@med.uni-jena.de.

作者： Andreas,Hochhaus ^[1] ; Carlo,Gambacorti-Passerini ^[2] ; Camille,Abboud ^[3] ; Bjørn Tore,Gjertsen ^[4] ; Tim H,Brümmendorf ^[5] ; B Douglas,Smith ^[6] ; Thomas,Ernst ^[7] ; Pilar,Giraldo-Castellano ^[8] ; Ulla,Olsson-Strömberg ^[9] ; Susanne,Saussele ^[10] ; Nathalie,Bardy-Bouxin ^[11] ; Andrea,Viqueira ^[12] ; Eric,Leip ^[13] ; T Alexander,Russell-Smith ^[14] ; Jocelyn,Leone ^[13] ; Gianantonio,Rosti ^[15] ; Justin,Watts ^[16] ; Francis J,Giles ^[17] ; BYOND Study Investigators

作者单位： Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany. andreas.hochhaus@med.uni-jena.de. ^[1] University of Milano-Bicocca, Monza, Italy. ^[2] Washington University School of Medicine, St. Louis, MO, USA. ^[3] Haukeland University Hospital, Helse Bergen, and University of Bergen, Bergen, Norway. ^[4] Universitätsklinikum RWTH Aachen, Aachen, Germany. ^[5] Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. ^[6] Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany. ^[7] CIBER Enfermedades Raras, Miguel Servet University Hospital, Zaragoza, Spain. ^[8] University of Uppsala and Department of Hematology, University Hospital, Uppsala, Sweden. ^[9] Universitätsmedizin Mannheim, Heidelberg University, Mannheim, Germany. ^[10] Pfizer International Operation-Oncology, Paris, France. ^[11] Pfizer SLU, Madrid, Spain. ^[12] Pfizer Inc, Cambridge, MA, USA. ^[13] Pfizer Inc, New York, NY, USA. ^[14] University Hospital, University of Bologna, Bologna, Italy. ^[15] University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA. ^[16] Developmental Therapeutics Consortium, Chicago, IL, USA. ^[17]